BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

395 related articles for article (PubMed ID: 2474353)

  • 1. Differential release of histamine and eicosanoids from human skin mast cells activated by IgE-dependent and non-immunological stimuli.
    Benyon RC; Robinson C; Church MK
    Br J Pharmacol; 1989 Jul; 97(3):898-904. PubMed ID: 2474353
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The IgE- and calcium-dependent release of eicosanoids and histamine from human purified cutaneous mast cells.
    Robinson C; Benyon C; Holgate ST; Church MK
    J Invest Dermatol; 1989 Sep; 93(3):397-404. PubMed ID: 2504819
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human skin mast cells: their dispersion, purification, and secretory characterization.
    Benyon RC; Lowman MA; Church MK
    J Immunol; 1987 Feb; 138(3):861-7. PubMed ID: 2433332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human mast cell heterogeneity: histamine release from mast cells dispersed from skin, lung, adenoids, tonsils, and colon in response to IgE-dependent and nonimmunologic stimuli.
    Lowman MA; Rees PH; Benyon RC; Church MK
    J Allergy Clin Immunol; 1988 Mar; 81(3):590-7. PubMed ID: 2450114
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Generation of leukotriene C4, leukotriene B4, and prostaglandin D2 by immunologically activated rat intestinal mucosa mast cells.
    Heavey DJ; Ernst PB; Stevens RL; Befus AD; Bienenstock J; Austen KF
    J Immunol; 1988 Mar; 140(6):1953-7. PubMed ID: 2450136
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of neuropeptide-induced histamine release from human dispersed skin mast cells.
    Lowman MA; Benyon RC; Church MK
    Br J Pharmacol; 1988 Sep; 95(1):121-30. PubMed ID: 2464382
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isoproterenol-induced inhibition of immunoglobulin E-mediated release of histamine and arachidonic acid metabolites from the human lung mast cell.
    Undem BJ; Peachell PT; Lichtenstein LM
    J Pharmacol Exp Ther; 1988 Oct; 247(1):209-17. PubMed ID: 2459368
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of primate bronchoalveolar mast cells. I. IgE-dependent release of histamine, leukotrienes, and prostaglandins.
    Wells E; Harper ST; Jackson CG; Mann J; Eady RP
    J Immunol; 1986 Dec; 137(12):3933-40. PubMed ID: 2431048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The human recombinant c-kit receptor ligand, rhSCF, induces mediator release from human cutaneous mast cells and enhances IgE-dependent mediator release from both skin mast cells and peripheral blood basophils.
    Columbo M; Horowitz EM; Botana LM; MacGlashan DW; Bochner BS; Gillis S; Zsebo KM; Galli SJ; Lichtenstein LM
    J Immunol; 1992 Jul; 149(2):599-608. PubMed ID: 1378071
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anaphylactic- and calcium-dependent generation of prostaglandin D2 (PGD2), thromboxane B2, and other cyclooxygenase products of arachidonic acid by dispersed human lung cells and relationship to histamine release.
    Holgate ST; Burns GB; Robinson C; Church MK
    J Immunol; 1984 Oct; 133(4):2138-44. PubMed ID: 6206153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuropeptide-induced secretion from human skin mast cells.
    Church MK; el-Lati S; Caulfield JP
    Int Arch Allergy Appl Immunol; 1991; 94(1-4):310-8. PubMed ID: 1718893
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IgE-mediated release of leukotriene C4, chondroitin sulfate E proteoglycan, beta-hexosaminidase, and histamine from cultured bone marrow-derived mouse mast cells.
    Razin E; Mencia-Huerta JM; Stevens RL; Lewis RA; Liu FT; Corey E; Austen KF
    J Exp Med; 1983 Jan; 157(1):189-201. PubMed ID: 6184439
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The immunoglobulin E- and calcium-dependent release of histamine and eicosanoids from human dispersed mastocytosis spleen cells.
    Robinson C; Benyon RC; Agius RM; Jones DB; Wright DH; Holgate ST
    J Invest Dermatol; 1988 Mar; 90(3):359-65. PubMed ID: 2450144
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction of neuropeptides with human mast cells.
    Church MK; Lowman MA; Robinson C; Holgate ST; Benyon RC
    Int Arch Allergy Appl Immunol; 1989; 88(1-2):70-8. PubMed ID: 2468622
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mediator secretion from human skin mast cells provoked by immunological and non-immunological stimulation.
    Church MK; Okayama Y; el-Lati S
    Skin Pharmacol; 1991; 4 Suppl 1():15-24. PubMed ID: 1722414
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human basophil/mast cell releasability. IX. Heterogeneity of the effects of opioids on mediator release.
    Stellato C; Cirillo R; de Paulis A; Casolaro V; Patella V; Mastronardi P; Mazzarella B; Marone G
    Anesthesiology; 1992 Nov; 77(5):932-40. PubMed ID: 1280014
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential inhibition of histamine release from mast cells by protein kinase C inhibitors: staurosporine and K-252a.
    White JR; Zembryki D; Hanna N; Mong S
    Biochem Pharmacol; 1990 Aug; 40(3):447-56. PubMed ID: 1696482
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostaglandin and histamine release from stimulated rat peritoneal mast cells.
    Ennis M; Barrow SE; Blair IA
    Agents Actions; 1984 Apr; 14(3-4):397-400. PubMed ID: 6203356
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human basophil/mast cell releasability. VII. Heterogeneity of the effect of adenosine on mediator secretion.
    Marone G; Cirillo R; Genovese A; Marino O; Quattrin S
    Life Sci; 1989; 45(19):1745-54. PubMed ID: 2480501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Co-culture of human lung-derived mast cells with mouse 3T3 fibroblasts: morphology and IgE-mediated release of histamine, prostaglandin D2, and leukotrienes.
    Levi-Schaffer F; Austen KF; Caulfield JP; Hein A; Gravallese PM; Stevens RL
    J Immunol; 1987 Jul; 139(2):494-500. PubMed ID: 2439587
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.